
Full profile: /officials/P000614
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Currently in
The Federal Trade Commission would be required to investigate whether companies are using misleading or unfair advertising when marketing specialized infant formula designed for premature babies, then report their findings to Congress. Based on what they find, the FTC would be authorized to create new rules to stop any deceptive marketing practices in this industry. This would protect parents and hospitals from being misled about the benefits or contents of these medical products.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.